Skip to content

The Effects of Changing Light Levels on Contrast Sensitivity in Patients With Glaucoma

The Effects of chaNging LIGHT Levels on Contrast sENsitivity in Patients With Glaucoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04061343
Acronym
ENLIGHTEN
Enrollment
115
Registered
2019-08-19
Start date
2018-11-20
Completion date
2021-03-16
Last updated
2023-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The study is a prospective observational study where participants will be recruited from the Ophthalmology department (Outpatient department, Eye Casualty). Only one research visit will be required. Participants will be asked to fill in a set of questionnaires (Visual Functioning Questionnaire-15(61), Low Luminance Questionnaire(62)) assessing their quality of life and vision and their full medical history will be collected. Then they will have their contrast sensitivity tested under various light conditions. If a recent visual field test is not available, that might be performed as part of the study.

Detailed description

The purpose of our, real world study is to explore contrast sensitivity differences after changes in ambient light setting in patients with glaucoma compared with controls (patients with ocular hypertension). Participants will be asked to read a Pelli- Robson chart under photopic (bright light conditions) and mesopic (intermediate light conditions); followed by scotopic conditions (dim light conditions). This chart is a fast, easy, and effective way to measure spatial contrast sensitivity with reliable and reproducible results(60). This study will therefore help clinicians gain more insight into glaucoma related disability and provide a possible additional tool to visual field testing in patients with advanced glaucoma where VF testing may be hampered by floor effects.

Interventions

None listed

Sponsors

Portsmouth Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Male or Female, aged 40 years or above. * Diagnosis of glaucoma (including primary open angle glaucoma, pigment dispersion syndrome, pseudoexfoliation, normal tension glaucoma, chronic angle closure glaucoma, narrow angle glaucoma) or ocular hypertension * Willing and able to give informed consent for participation in the study. * Best Corrected Visual Acuity equal or better than 6/12 as measured with the Snellen Chart

Exclusion criteria

* • Neovascular, uveitic, acute angle closure glaucoma * Non-glaucomatous ocular disease such as AMD, Diabetic retinopathy, Inherited eye diseases * Visually significant cataracts (Distance VA ≤ 6/12 (0.30 LogMAR) and grade ≥ grade 2 nuclear sclerosis.) * Current use of miotic glaucoma medication * Incisional or laser eye surgery within 3 months of enrolment * Severely impaired cognition * Self-reported physical ability limiting function (e.g. stroke) * Unreliable visual fields (SITA Standard or SITA Fast: fixation losses \>20% or false-positive errors \>33% or false-negative errors \>33%)

Design outcomes

Primary

MeasureTime frameDescription
vision-related quality of life in patients with glaucoma1 day study visitassessed using the the visual functioning questionnaire - 25 questionnaire
Visual functionthrough study completion, an average of 1 yearassessed using the low luminance questionnaire

Secondary

MeasureTime frameDescription
To correlate visual impairment with contrast sensitivity resultsthrough study completion, an average of 1 yearmeasured with Quality of Life questionnaires (Visual Functioning Questionnaire-25, Low Luminance Questionnaire)
Contrast Sensitivitiythrough study completion, an average of 1 yearParticipants' contrast sensitivity will be tested under photopic (bright light conditions), mesopic (intermediate light conditions) and/or scotopic conditions (dim light conditions).

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026